Two novel T cell epitope prediction algorithms based on MHC-binding motifs; comparison of predicted and published epitopes from Mycobacterium tuberculosis and HIV protein sequences

Vaccine

Volumn 13, Issue 6, 1995, Pages 581-591

  Meister, Gabriel E ^a   Roberts, Caroline G P ^a   Berzofsky, Jay A ^b   De Groot, Anne S ^a  

^a BROWN UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

MHC binding; T cell epitopes; vaccine

Indexed keywords

BCG VACCINE; EPITOPE; HLA ANTIGEN;

ARTICLE; COMPUTER PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; MAJOR HISTOCOMPATIBILITY COMPLEX; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

ALGORITHMS; ANIMAL; ANTIGENS, BACTERIAL; BINDING SITES; COMPARATIVE STUDY; EPITOPES; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HIV ANTIGENS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MYCOBACTERIUM TUBERCULOSIS; PREDICTIVE VALUE OF TESTS; SUPPORT, U.S. GOV'T, P.H.S.; T-LYMPHOCYTES;

EID: 0029066338     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0264-410X(94)00014-E     Document Type: Article

References (81)

1. Emerging principles for the recognition of peptide antigens by MHC class I molecules
2. The biochemistry and cell biology of antigen processing and presentation
3. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules
4. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles
5. Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules
6. Peptides of 23 residues or greater are required to stimulate a high affinity class II-restricted T cell response
7. Sequence analysis of peptides bound to MHC class II molecules
8. Differences in antigen presentation to MHC class I- and class II-restricted influenza virus-specific cytolytic T lymphocyte clones
9. Recognition of peptide epitopes of the 16,000 MW antigen of Mycobacterium tuberculosis by murine T cells
10. Mapping of T helper cell epitopes by using peptides spanning the 19-kDa protein of Mycobacterium tuberculosis: evidence for unique and shared epitopes in the stimulation of antibody and delayed-type hypersensitivity responses
11. Prediction of immunodominant helper T cell antigenic sites from the primary sequence
12. The amphipathic helix as a structural feature involved in T cell recognition
13. Strong conformational propensities enhance T cell antigenicity
14. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide
15. Hydrophobic strip-of-helix algorithm for selection of T cell-presented peptides
16. A sequence pattern common to T cell epitopes
17. Comparison of actual and random-positioning-model distributions of peptide scavenging and T cell-presented sites in antigenic proteins
18. CD8+ T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo
19. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes
20. A pattern search method for putative anchor residues in T cell epitopes
21. Sequence features that correlate with MHC restriction
22. Endogenous peptides with distinct amino acid anchor residue motifs bind to HLA-A1 and HLA-B8
23. Random association between the peptide repertoire of A2.1 class I and several different DR class II molecules
24. Endogenous peptides bound to HLA-A3 possess a specific combination of anchor residues that permit identification of potential antigenic peptides
25. An HLA-A11-specific motif in nonamer peptides derived from viral and cellular proteins
26. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle
27. Naturally processed HLA class I bound peptides from c-myc-transfected cells reveal allele-specific motifs
28. Prediction of an HLA B8-restricted influenza epitope by motif
29. Identification of self peptides bound to purified HLA-B27
30. Molecular analysis of the association of HLA-B53 and resistance to severe malaria
31. Definition of a DQ3.1 specific binding motif
32. Identification of a motif for HLA-DR1 binding peptides using M13 display libraries
33. Promiscuous and allele-specific anchors in HLA-DR-binding peptides
34. Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue contact motif
35. Truncation analysis of several DR binding epitopes
36. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles
37. ∗0301 molecules recognize a structural motif distinct from the one recognized by most DRß, alleles
38. HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions
39. Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides
40. Prediction of major histocompatibility complex binding regions of protein antigens by sequence pattern analysis
41. Comparison of structural requirements for interactionof the same peptide with I-Ek and I-Ed molecules in the activation of MHC class II-restricted T cells
42. H-2Dd exploits a four residue peptide binding motif
43. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs
44. Structure of peptides associated with MHC class I molecules
45. Characteristics of endogenous peptides eluted from class I MHC molecule HLA-B7 detemined by mass spectrometry and computer modeling
46. Prominent role of secondary anchor residues in peptide binding to HLA-A2.1 molecules
47. Can one predict antigenic peptides for MHC class I-restricted cytotoxic T lymphocytes useful for vaccination?
48. Primary in vivo responses to ovalbumin. Probing the predictive value of the Kb binding motif
49. Identification of peptide sequences that potentially trigger HLA-A2.1-restricted cytotoxic T lymphocytes
50. Identification of B- and T-cell epitopes within the MTP40 protein of Mycobacterium tuberculosis and their correlation with the disease course
51. Recognition of peptide epitopes of the 16,000 MW antigen of Mycobacterium tuberculosis by murine T cells
52. Prediction and identification of an HLA-DR-restricted T cell determinant in the 19-kDa protein of Mycobacterium tuberculosis
53. Lymphocyte responses to DR4/1-restricted peptides in rheumatoid arthritis: the immunodominant T cell epitope on the 19-kd Mycobacterium tuberculosis protein
54. The effect of lipoylation on CD4 T-cell recognition of the 19,000 MW Mycobacterium tuberculosis antigen
55. Mapping of TH1 helper T-cell epitopes on major secreted mycobacterial antigen 85A in mice infected with live Mycobacterium bovis BCG
56. T cell repertoire in tuberculosis: selective anergy to an immunodominant epitope of the 38-kDa antigen in patients with active disease
57. Identification of T cell stimulatory peptides from the 38-kDa protein of Mycobacterium tuberculosis
58. Mapping of T cell epitopes using recombinant antigens and synthetic peptides
59. A Mycobacterium leprae-specific human T cell epitope cross-reactive with an HLA-DR2 peptide
60. Mycobacterium leprae-specific T cells from a tuberculoid leprosy patient suppress HLA-DR3-restricted T cell responses to an immunodominant epitope on the 65-kDa hsp of Mycobacteria
61. Use of recombinant antigens expressed in Escherichia coli K-12 to map B-cell and T-cell epitopes on the immunodominant 65-kilodalton protein of Mycobacterium bovis BCG
62. Epitopes of the Mycobacterium tuberculosis 65-kilodalton protein antigen as recognized by human T cells
63. In vivo response of murine gamma-delta T cells to a heat shock protein-derived peptide
64. Lymphocytes from healthy individuals with specificity to self-epitopes shared by the mycobacterial and human 65-KD heat shock protein
65. Genetically permissive recognition of adjacent epitopes from the 19-kDa antigen of Mycobacterium tuberculosis by human and murine T cells
66. Immunogenicity of the human immunodeficiency virus (HIV) recombinant nef gene product, mapping of T-cell and B-cell epitopes in immunized chimpanzees
67. Six epitopes reacting with human cytotoxic CD8+ T cells in the central region of the HIV-1 nef protein
68. Human immunodeficiency virus reverse transcriptase T helper epitopes identified in mice and humans: correlation with a cytotoxic T cell epitope
69. Carboxyl-terminal and central regions of human immunodeficiency virus-1 nef recognized by cytotoxic T lymphocytes from lymphoid organs: an in vitro limiting dilution analysis
70. Immunization with soluble protein-pulsed spleen cells induces class I-restricted cytotoxic T lymphocytes that recognize immunodominant epitopic peptides from Plasmodium falciparum and HIV-1
71. Mapping the fine specificity of a cytolytic T cell response to HIV-1 nef protein
72. Cytotoxic T lymphocytes from HIV-1 seropositive individuals recognize immunodominant epitopes in gp 160 and reverse transcriptase
73. Broad recognition of cytotoxic T cell epitopes from the HIV-1 protein with multiple class I histocompatibility molecules
74. An immunodominant epitope of the human immunodeficiency virus envelope glycoprotein gp160 recognized by class I major histocompatibility complex molecule-restricted murine cytotoxic T lymphocytes
75. Specific lysis of human immunodeficiency virus type 1-infected cells by a HLA-A3.1-restricted CD8+ cytotoxic T-lymphocyte that recognizes a conserved peptide sequence within the gp41 subunit of the envelope protein
76. Universally immunogenic T cell epitopes: promiscuous binding to human MHC class II and promiscuous recognition by T cells
77. A novel approach to the generation of high affinity class II-binding peptides
78. Cytotoxic T cell activity antagonized by naturally occurring HIV-1 gag variants
79. Natural variants of cytotoxic epitopes are T cell receptor antagonists for antiviral cytotoxic T cells
80. The importance of dominant negative effects of amino acid side chain substitution in peptide-MHC molecule interactions and T cell recognition